Recent News

Latest GeoVax News

  • Home
    Home This is where you can find all the blog posts throughout the site.
  • Categories
    Categories Displays a list of categories from this blog.
  • Tags
    Tags Displays a list of tags that have been used in the blog.
11
2nd Deadliest Outbreak in History Highlights the Need for a Safe and Effective Vaccine ATLANTA, GA, December 12, 2018 – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology...
Last modified on Continue reading
186
world logo2
      Recognizing the Importance of Partnerships  ATLANTA, GA, December 3, 2018 – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines,...
Last modified on Continue reading
879
Innovative Combination Vaccine Advancing in Clinical Trials ATLANTA, GA, November 28, 2018 – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, today provided...
Last modified on Continue reading
395
Combined Technologies May Yield Therapies for Multiple Cancer Indications ATLANTA, GA, November 19, 2018 – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines,...
Last modified on Continue reading
1108
GeoVax Continues Expansion of International Collaborative Efforts for its Unique MVA-VLP Vaccine Technology ATLANTA, GA, November 13, 2018 – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology...
Last modified on Continue reading